VR Logo

Syngene International Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Scientific research and development

Incorporated: 1993

Chairman: --

Managing Director: Kiran Mazumdar Shaw

Group: --

Listing: NSE: SYNGENE, BSE: 539268

Headquarters: Bengaluru, Karnataka

Website: www.syngeneintl.com

Key Facts

Market cap: R 14,726.00 Cr

Revenue (TTM): R 2,011.90 Cr

Earnings (TTM): R 412.10 Cr

Cash: R 1,152.90 Cr

Total Debt: R 813.30 Cr

Promoters' ownership: 70.69%

Liquidity: High

52 Week range: R 212.55 - 390.00

Face value: R10.00

Shares outstanding: 40,00,00,000

10 Years Aggregate:

  • CFO: 2,526.08 Cr
  • EBITDA: 2,678.01 Cr
  • Net Profit: 1,703.41 Cr

Stock Performance

Time Period Syngene International S&P BSE Healthcare S&P BSE Mid Cap
YTD14.6320.33-16.13
1 month16.546.8710.21
3 months22.2514.23-13.84
1 Year7.6821.43-17.32
3 Years15.075.22-5.38
5 Years--0.313.92
10 Years--11.356.18
As on 05-Jun-2020
Year Syngene International S&P BSE Mid Cap S&P BSE Healthcare
201914.86-3.05-3.55
20183.46-13.31-5.89
2017-3.6548.130.49
201634.517.97-12.88

Review & Analysis